Literature DB >> 92860

An A,B,C,D of cancer chemotherapy.

E Y Chan, R J Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 92860      PMCID： PMC1238732     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  16 in total

Review 1.  Clinical comparison of the nitrosoureas.

Authors:  T H Wasserman; M Slavik; S K Carter
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

2.  Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.

Authors:  R T Eagan; R G Hahn; R P Myers
Journal:  Cancer Treat Rep       Date:  1976-01

3.  Combination chemotherapy of advanced lung cancer: a randomized trial.

Authors:  H H Hansen; O S Selawry; R Simon; D T Carr; C E van Wyk; R D Tucker; R Sealy
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

Review 4.  Adriamycin. A new anticancer drug with significant clinical activity.

Authors:  R H Blum; S K Carter
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

5.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

6.  Adriamycin cardiotoxicity in man.

Authors:  J J Rinehart; R P Lewis; S P Balcerzak
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

7.  Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.

Authors:  J A Gottlieb; L H Baker; J M Quagliana; J K Luce; J P Whitecar; J G Sinkovics; S E Rivkin; R Brownlee; E Frei
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

8.  Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.

Authors:  C G Moertel; A J Schutt; R G Hahn; R J Reitemeier
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

9.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.

Authors:  G Bonadonna; R Zucali; S Monfardini; M De Lena; C Uslenghi
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

10.  Single-agent chemotherapy of brain tumors. A five-year review.

Authors:  C B Wilson; P Gutin; E B Boldrey; D Drafts; V A Levin; K J Enot
Journal:  Arch Neurol       Date:  1976-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.